Literature DB >> 3829585

Reproducibility of vibratory perception thresholds in patients with diabetic neuropathy.

F W Bertelsmann, J J Heimans, J C van Rooy, R J Heine, E A van der Veen.   

Abstract

Using an improved biothesiometer, intraindividual variability of vibratory perception thresholds was investigated in 60 healthy volunteers, 39 diabetics with diabetic neuropathy and 21 diabetics without symptoms or signs of neuropathy. Reproducibility of vibratory perception thresholds was satisfactory in the normal subjects and most diabetic patients. However, a considerable variability was found in some diabetics. For determination of vibratory thresholds, vibrometers with amplitude measurement and controlled application pressure are recommended. In longitudinal studies of patients with diabetic neuropathy, a combination of neurophysiological test methods should be used to monitor impaired nerve function.

Entities:  

Mesh:

Year:  1986        PMID: 3829585

Source DB:  PubMed          Journal:  Diabetes Res        ISSN: 0265-5985


  4 in total

1.  Measurement precision of a portable instrument to assess vibrotactile perception threshold.

Authors:  B Frenette; D Mergler; J Ferraris
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1990

2.  Peripheral nerve function in relation to quality of metabolic control in diabetes.

Authors:  F W Bertelsmann; J J Heimans; J C van Rooy; C Popp-Snijders; E A van der Veen
Journal:  J Neurol       Date:  1987-06       Impact factor: 4.849

3.  Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion.

Authors:  F W Bertelsmann; J J Heimans; J C Van Rooy; H F Dankmeijer; S L Visser; E A Van der Veen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

4.  Neurosensory disturbances after immediate loading of implants in the anterior mandible: an initial questionnaire approach followed by a psychophysical assessment.

Authors:  M Abarca; D van Steenberghe; C Malevez; J De Ridder; R Jacobs
Journal:  Clin Oral Investig       Date:  2006-08-26       Impact factor: 3.573

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.